SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 51 filers reported holding SUTRO BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | +4.8% | 62,579 | +40.7% | 0.00% | – |
| Q2 2023 | $207 | -63.0% | 44,486 | -63.3% | 0.00% | – |
| Q1 2023 | $559 | -15.4% | 121,144 | +47.9% | 0.00% | – |
| Q4 2022 | $661 | -99.4% | 81,899 | +300.9% | 0.00% | – |
| Q3 2022 | $114,000 | -8.8% | 20,429 | -14.3% | 0.00% | – |
| Q2 2022 | $125,000 | -71.7% | 23,838 | -55.5% | 0.00% | – |
| Q1 2022 | $441,000 | -95.8% | 53,591 | -92.4% | 0.00% | -100.0% |
| Q4 2021 | $10,546,000 | +68.8% | 708,774 | +114.4% | 0.00% | -33.3% |
| Q3 2021 | $6,247,000 | +40.6% | 330,624 | +38.3% | 0.00% | +50.0% |
| Q2 2021 | $4,443,000 | -24.9% | 238,994 | -8.1% | 0.00% | -33.3% |
| Q1 2021 | $5,919,000 | +18.5% | 260,123 | +13.0% | 0.00% | 0.0% |
| Q4 2020 | $4,995,000 | +107.9% | 230,119 | -3.8% | 0.00% | +200.0% |
| Q3 2020 | $2,403,000 | +30.5% | 239,125 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $1,841,000 | -21.5% | 237,359 | +3.2% | 0.00% | -50.0% |
| Q1 2020 | $2,346,000 | +1061.4% | 229,941 | +1156.6% | 0.00% | – |
| Q4 2019 | $202,000 | +74.1% | 18,299 | +43.7% | 0.00% | – |
| Q3 2019 | $116,000 | +4.5% | 12,732 | +30.9% | 0.00% | – |
| Q2 2019 | $111,000 | +428.6% | 9,726 | +438.5% | 0.00% | – |
| Q1 2019 | $21,000 | +133.3% | 1,806 | +80.8% | 0.00% | – |
| Q4 2018 | $9,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |